Overview

Quetiapine Augmentation in Severe Obsessive Compulsive Disorder

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of quetiapine or placebo added to baseline treatment of SSRI/clomipramine for the treatment of OCD in adult subjects.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Clomipramine
Quetiapine Fumarate